Stephens downgraded NextGen Healthcare to Equal Weight from Overweight with a price target of $23.95, down from $24.00, after NextGen agreed to be acquired by Thoma Bravo for $23.95 per share. The analyst, who expects the deal to close by calendar year-end given that this deal was a result of an organized process and has unanimous approval by the board and “minimal regulatory concerns,” is changing his Best Idea from NextGen to cash.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NXGN:
- NextGen (NASDAQ:NXGN) Jumps on Acquisition Deal with Thoma Bravo
- NextGen Healthcare to be acquired by Thoma Bravo for $23.95 per share in cash
- Thoma Bravo in advanced talks to buy NextGen Healthcare, Bloomberg says
- NextGen Healthcare (NASDAQ:NXGN) Nears Acquisition by Thoma Bravo
- Nvidia upgraded, CrowdStrike downgraded: Wall Street’s top analyst calls
